Rooted in industry-academia collaboration with NIDVD at Xiamen University, INNOBIOMAX leverages full-matrix expression (E. coli, CHO, HEK293, insect cells), and multi-species antibody screening to develop 300+ high-performance bioactive raw materials. INNOBIOMAX antigens and antibodies seamlessly adapt to Lateral Flow, EIA, CLIA, PCR assays and Quality Controls. Powering HIV urine home tests, HIV blood tests, and TB-IGRA kits prequalified or recommended by the WHO, our materials earn a global recognition of our core technology's power to advance global healthcare!